In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated

William Bain1,2, Brian Ahn3, Hernán F Peñaloza1

  • 1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh.

Abstract

Insights

Loss of capsule gene wcaJ in Klebsiella pneumoniae increases resistance to complement, aiding bloodstream infection survival. This mutation enhances complement binding and opsonophagocytosis, impacting virulence.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Klebsiella pneumoniae carbapenemase-producing K pneumoniae (KPC-Kp) bloodstream infections are a significant cause of mortality.
  • Complement is a critical host defense mechanism against bloodstream infections.

Purpose of the Study:

  • To investigate the mechanisms of complement resistance in clinical KPC-Kp isolates.
  • To understand how KPC-Kp evades complement-mediated killing during bloodstream infections.

Main Methods:

  • Growth of KPC-Kp isolates in human serum was assessed.
  • Whole genome sequencing was performed on serial isolates from a single patient.
  • Complement resistance, binding, opsonophagocytosis, and in vivo infection models were utilized.

Main Results:

  • Serum resistance was observed in 27% of KPC-Kp isolates.
  • A loss-of-function mutation in the wcaJ gene was identified in genetically related isolates.
  • wcaJ disruption decreased capsule, increased complement resistance and binding, and enhanced opsonophagocytosis.

Conclusions:

  • Loss of wcaJ function enhances complement resistance and binding, potentially promoting KPC-Kp persistence.
  • The findings suggest a trade-off between bloodstream fitness and tissue virulence.
  • Targeting capsule biosynthesis could be a strategy to combat KPC-Kp infections.